Novo Nordisk reported a surge in earnings and revenue on Thursday as it continues to benefit from the popularity of its weight-loss drugs. However, the company is still struggling with raising the supply of the drugs to meet demand.
Source: finance.yahoo.com
Related posts:
What history says happens to stocks if there's a recession
‘The midterms could be a positive catalyst for stocks in Q4′ says RBC. Here are 2 stock picks with a...
Here’s what Morgan Stanley says will fuel another decline in stocks
Monday was an ugly one for the stock market headed to Christmas. Here’s what history says about retu...
If Congress doesn’t raise the debt ceiling, what does that mean for you?